IL147023A0 - Stable xylometazoline and oxymetazoline solution - Google Patents

Stable xylometazoline and oxymetazoline solution

Info

Publication number
IL147023A0
IL147023A0 IL14702300A IL14702300A IL147023A0 IL 147023 A0 IL147023 A0 IL 147023A0 IL 14702300 A IL14702300 A IL 14702300A IL 14702300 A IL14702300 A IL 14702300A IL 147023 A0 IL147023 A0 IL 147023A0
Authority
IL
Israel
Prior art keywords
oxymetazoline solution
xylometazoline
stable
stable xylometazoline
oxymetazoline
Prior art date
Application number
IL14702300A
Other languages
English (en)
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23322017&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL147023(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of IL147023A0 publication Critical patent/IL147023A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Inorganic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Cosmetics (AREA)
IL14702300A 1999-06-22 2000-06-17 Stable xylometazoline and oxymetazoline solution IL147023A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33778999A 1999-06-22 1999-06-22
PCT/EP2000/005583 WO2000078297A2 (de) 1999-06-22 2000-06-17 Stabile xylometazolin- und oxymetazolinlösung

Publications (1)

Publication Number Publication Date
IL147023A0 true IL147023A0 (en) 2002-08-14

Family

ID=23322017

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14702300A IL147023A0 (en) 1999-06-22 2000-06-17 Stable xylometazoline and oxymetazoline solution

Country Status (22)

Country Link
US (2) US20040191177A1 (xx)
EP (1) EP1194145B1 (xx)
JP (1) JP2003502361A (xx)
KR (1) KR20020012001A (xx)
CN (1) CN1164271C (xx)
AT (1) ATE232099T1 (xx)
AU (1) AU765736B2 (xx)
BR (1) BR0011950A (xx)
CA (1) CA2376121C (xx)
CZ (1) CZ295595B6 (xx)
DE (1) DE50001217D1 (xx)
EA (1) EA003329B1 (xx)
ES (1) ES2188563T3 (xx)
HK (1) HK1045945B (xx)
HU (1) HUP0201700A3 (xx)
IL (1) IL147023A0 (xx)
MX (1) MXPA01012912A (xx)
PL (1) PL197542B1 (xx)
PT (1) PT1194145E (xx)
TR (1) TR200103694T2 (xx)
WO (1) WO2000078297A2 (xx)
ZA (1) ZA200110386B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU226527B1 (hu) 2001-09-18 2009-03-30 Nycomed Danmark Aps Készítmények nátha kezelésére
JP2005533076A (ja) * 2002-06-20 2005-11-04 ノバルテイス・コンシユーマー・ヘルス・エス・アー ムコ多糖及びプロピレングリコールを含む鼻用組成物
WO2004024187A2 (en) * 2002-09-13 2004-03-25 Zicam, Llc. Compositions to reduce congestion and methods for application thereof to the nasal membrane
DE10337186A1 (de) * 2003-08-13 2005-03-17 Merck Patent Gmbh Wässrige Wirkstoff-Lösung
JP2009535342A (ja) * 2006-04-26 2009-10-01 アーシエックス， インコーポレイテッド 眼瞼腫脹の予防および処置のための組成物
US20090136598A1 (en) * 2006-04-26 2009-05-28 Aciex, Inc. Compositions for the Treatment and Prevention of Eyelid Swelling
CN101912363A (zh) * 2010-07-29 2010-12-15 蔡海德 溶解超滤-喷雾干燥-分子分散包衣-水化制粒-冷冻干燥生产脂质体组合药物
UA117544C2 (uk) 2014-12-24 2018-08-10 Ядран - Галенскі Лабораторій Д.Д. Назальна композиція із вмістом морської води як ексципієнтом, що покращує стабільність
WO2023046590A1 (en) 2021-09-22 2023-03-30 Jadran - Galenski Laboratorij D.D. An improved pharmaceutical composition for nasal use, preparation, and use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4603131A (en) * 1982-04-26 1986-07-29 Bernstein Joel E Method and composition for treating and preventing irritation of the mucous membranes of the nose
US5114979A (en) * 1989-10-18 1992-05-19 Schering Corporation Fruity flavored nasal decongestant composition
US4970240A (en) * 1989-10-18 1990-11-13 Schering Corporation Fruity flavored nasal decongestant composition
US5540930A (en) * 1993-10-25 1996-07-30 Pharmos Corporation Suspension of loteprednol etabonate for ear, eye, or nose treatment
DE19549421C2 (de) * 1995-11-10 1999-11-18 Klosterfrau Mcm Vetrieb Gmbh Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden
DE19542959C1 (de) * 1995-11-17 1996-10-24 Ursatec Verpackung Gmbh Vor Kontamination schützende Abgabevorrichtung für Fluide
ES2190477T3 (es) * 1995-11-17 2003-08-01 Ursatec Verpackung Gmbh Dispensador de fluidos diseñado para proteger el contenido de la contaminacion.
JP4603687B2 (ja) * 1998-01-30 2010-12-22 ノバルテイス・コンシユーマー・ヘルス・エス・アー 点鼻用液剤

Also Published As

Publication number Publication date
US20080011293A1 (en) 2008-01-17
EA003329B1 (ru) 2003-04-24
AU765736B2 (en) 2003-09-25
CZ295595B6 (cs) 2005-08-17
EP1194145B1 (de) 2003-02-05
CN1361689A (zh) 2002-07-31
EA200200042A1 (ru) 2002-06-27
TR200103694T2 (tr) 2002-04-22
HUP0201700A2 (hu) 2002-12-28
HUP0201700A3 (en) 2003-02-28
DE50001217D1 (de) 2003-03-13
MXPA01012912A (es) 2002-09-18
CA2376121A1 (en) 2000-12-28
WO2000078297A3 (de) 2001-03-01
PL197542B1 (pl) 2008-04-30
CZ20014568A3 (cs) 2002-03-13
EP1194145A2 (de) 2002-04-10
AU6150600A (en) 2001-01-09
JP2003502361A (ja) 2003-01-21
WO2000078297A2 (de) 2000-12-28
PL352354A1 (en) 2003-08-11
BR0011950A (pt) 2002-03-12
US20040191177A1 (en) 2004-09-30
HK1045945B (zh) 2005-01-28
PT1194145E (pt) 2003-06-30
KR20020012001A (ko) 2002-02-09
ZA200110386B (en) 2003-04-22
ES2188563T3 (es) 2003-07-01
HK1045945A1 (en) 2002-12-20
CN1164271C (zh) 2004-09-01
ATE232099T1 (de) 2003-02-15
CA2376121C (en) 2008-06-10

Similar Documents

Publication Publication Date Title
SG147286A1 (en) Manufacture of polyglumate-therapeutic agent conjugates
HK1071514A1 (en) Aqueous compositions containing metronidazole
AU2001233111A1 (en) Optimized delivery of web application code
PL351796A1 (en) Solutions of polyurethane resins with alkoxysilate-type structural units
EP1337206A4 (en) LIMBS MASS STABILISATOR
MXPA03002857A (es) Hidroxiesteres de 7-desmetil-rapamicina.
MXPA03000136A (es) Derivados anticonvulsivos utiles para prevenir el desarrollo de la diabetes mellitus de tipo ii o del sindromex.
HUP0301646A3 (en) Clear aqueous anaesthetic composition
HK1045945A1 (en) Stable xylometazoline and oxymetazoline solution.
BG106316A (en) Ambroxol-containing lozenge
ZA200108018B (en) Pyrrolidincarbonylamino cyclic disulfides.
PL373734A1 (en) Mildew-resistant sealing compound formulations containing a benzothiophene-2-cyclohexylcarboxamide-s,s-dioxide
HK1051179A1 (en) Prostaglandin e analogues.
ZA200109120B (en) Use of Arylalkanoylpyridazines.
IL146478A0 (en) Transparent envelope
DE69926019D1 (de) G.723.1 audiokodierer
AU1577302A (en) Hydrogen peroxide lyase regulatory region
AU2002215773A1 (en) Hydroperoxide lyase regulatory region
UA33933A (uk) Лімфогінний засіб
GB0105110D0 (en) Self adhesive spirit level
SI1154775T1 (en) Therapeutic aqueous composition containing a hexahydro-5-pyrimidinamine compound and a polyalkoxylated fatty alcohol
GB0128920D0 (en) Referencing
AU2892P (en) Cloudy Days Agapanthus orientalis
PT9672U (pt) Regulador de gas natural
ZA200206362B (en) Cyclic hexapeptide derivatives.